Co-infection with Influenza A and COVID-19

  • Venu Madhav Konala Department of Internal Medicine, Division of Medical Oncology, Ashland Bellefonte Cancer Center, Ashland, KY, USA
  • Sreedhar Adapa Department of Internal Medicine, Division of Nephrology, Adventist Medical Center, Hanford, CA, USA
  • Vijay Gayam Department of Medicine, Interfaith Medical Center, Brooklyn, NY, USA
  • Srikanth Naramala Department of Internal Medicine, Division of Rheumatology, Adventist Medical Center, Hanford, CA, USA
  • Subba Rao Daggubati Wise Health System, Decatur, TX, USA
  • Chetan Brahma Kammari Internal Medicine, Cape Fear Valley Hospital, Fayetteville, NC, USA
  • Avantika Chenna Phobe Putney Memorial Hospital, Medical College of Georgia, Albany, GA, USA

Keywords

Coronavirus, COVID-19, influenza, acute respiratory distress syndrome

Abstract

COVID-19, also called severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China. It has caused significant morbidity and mortality worldwide and has been declared a global pandemic by the WHO. Influenza occurs mainly during the winter, with the burden of disease determined by several factors, including the effectiveness of the vaccine that season, the characteristics of the circulating viruses, and how long the season lasts. We describe the case of a 66-year-old woman who was diagnosed with influenza A and COVID-19 co-infection.

VIEW THE ENTIRE ARTICLE

References

  • Balla M, Merugu GP, Patel M, Koduri NM, Gayam V, Adapa S, et al. COVID-19, modern pandemic: a systematic review from a front-line health care providers’ perspective. J Clin Med Res 2020;12(4):215–229.

  • John Hopkins University of Medicine Coronavirus Resource Center. Available from https://coronavirus.jhu.edu/map.html (accessed 11 April 2020).

  • Centers for Disease Control and Prevention. Influenza (Flu). Available from https://www.cdc.gov/flu/about/burden/index.html (accessed 11 April 2020).

  • Xing Q, Li GJ, Xing YH, Chen T, Li WJ, Ni W, et al. Precautions are needed for COVID-19 patients with coinfection of common respiratory pathogens. Available from http://dx.doi.org/10.2139/ssrn.3550013 (accessed 17 April 2020).

  • Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol 2020 Mar 20. doi: 10.1002/jmv.25781 [Epub ahead of print].

  • Gautret P, Lagier JC, Parola P, Meddeb L, Mailhe M, Doudier B, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949 [Epub ahead of print].
  • Published: 2020-04-20

    Issue: Vol 7 No 5 (view)

    Section: Articles

    How to cite:
    Konala, V. M., Adapa, S., Gayam, V., Naramala, S., Daggubati, S. R., Kammari, C. B., & Chenna, A. (2020). Co-infection with Influenza A and COVID-19. European Journal of Case Reports in Internal Medicine, 7(5). https://doi.org/https://doi.org/10.12890/2020_001656